BridgeBio Pharma, Inc.
BBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001743881
In the last 90 days, BridgeBio Pharma, Inc. insiders filed 0 open-market purchases and 3 sales; 478 institutions reported holding it in 13F filings for Q2 2026, worth $14.4B in total; Viking Global Investors is the only superinvestor holding it.
Key figures
- Market capClose on Nov 9, 2026
- $15.2B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $4.56M in total
- 3
- 13F holdersQ2 2026, +17 vs. previous quarter
- 478
- 13F valueReported value at the end of Q2 2026
- $14.4B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $502.1M
- +126.3% year over year
- Net income, FY2025
- -$732.9M
- No comparable prior period
- Free cash flow, FY2025
- -$447.0M
- No comparable prior period
- Revenue, Q3 FY2026
- $353.2M
- +192.6% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $732.9M (146.0% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 20.0M
- Shares sold short
- Change
- +326.3K
- +1.7% vs. previous
- Days to cover
- 7.68
- At average daily volume
Superinvestors holding BBIO, Q2 2026
Go to the superinvestors tab1 superinvestor reports holding BridgeBio Pharma, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Viking Global Investors
Andreas Halvorsen
2.1%
BridgeBio Pharma, Inc.'s share of the portfolio
- Shares
- 9,949,219
- Value
- $741.0M
Latest insider trades
See all insider tradesOpen-market purchases and sales by BridgeBio Pharma, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2026 (view filing)4:14 PM ET | Oct 30 | 4 days | Apuli MaricelChief Accounting Officer | SSale | −2.00K | $72.85 | −$145.7K | −1.6%120.7K after | 10b5-1 |
| Sep 21, 2026 (view filing)6:21 PM ET | Sep 17 | 4 days | Kumar NeilChief Executive Officer | SSale | −10.0K | $69.08 | −$690.8K | −2.0%495.7K after | 2 lots10b5-1 |
| Aug 20, 2026 (view filing)4:31 PM ET | Aug 18 | 2 days | Kumar NeilChief Executive Officer | SSale | −35.0K | $82.53 | −$2.89M | −12.6%243.3K after | 4 lots10b5-1 |
| Aug 20, 2026 (view filing)4:31 PM ET | Aug 19 | 1 day | Kumar NeilChief Executive Officer | SSale | −10.0K | $84.03 | −$840.3K | −1.9%505.7K after | 3 lots10b5-1 |
| Aug 3, 2026 (view filing)4:20 PM ET | Jul 30 | 4 days | Apuli MaricelChief Accounting Officer | SSale | −2.00K | $80.06 | −$160.1K | −1.5%127.4K after | 10b5-1 |
| Jul 13, 2026 (view filing)4:41 PM ET | Jul 9 | 4 days | Ellis AndreaDirector | SSale | −17.2K | $84.00 | −$1.44M | −43.2%22.6K after | 10b5-1 |
| Jul 13, 2026 (view filing)4:40 PM ET | Jul 9 | 4 days | Cook Jennifer E.Director | SSale | −148.6K | $88.54 | −$13.2M | −94.7%8.38K after | 2 lots10b5-1 |
| Jun 24, 2026 (view filing) | Jun 23-24 | 1 day | Cook Jennifer E.Director | SSale | −39.4K | $69.92 | −$2.75M | −82.4%8.38K after | 2 lots10b5-1 |
| Jun 24, 2026 (view filing) | Jun 22-23 | 2 days | Valantine HannahDirector | SSale | −5.00K | $68.25 | −$341.5K | −35.1%9.26K after | 2 lots10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Cook Jennifer E.Director | SSale | −90.2K | $66.63 | −$6.01M | −93.2%6.59K after | 2 lots10b5-1 |
Top 10 13F holders, Q2 2026
See all 478 holdersThe largest institutional positions in BridgeBio Pharma, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 14,110,278 | $1.05B | 0.43% | +14,110,278 | New |
| Kohlberg Kravis Roberts & Co. L.P. | 13,260,971 | $987.7M | 17.30% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 10,743,063 | $800.1M | 4.68% | +1,377,600+14.7% | Added |
| BlackRock, Inc. | 10,287,156 | $766.2M | 0.01% | −3,920,601−27.6% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 9,949,219 | $741.0M | 2.11% | −1,893,215−16.0% | Reduced |
| Vanguard Capital Management LLC | 7,898,973 | $588.3M | 0.01% | +139,478+1.8% | Added |
| Vanguard Portfolio Management LLC | 7,656,722 | $570.3M | 0.03% | −423,851−5.2% | Reduced |
| Wellington Management Group LLP | 5,308,924 | $395.4M | 0.07% | +2,824,971+113.7% | Added |
| Two Sigma Investments, LP | 4,722,185 | $351.7M | 0.26% | +1,601,554+51.3% | Added |
| Aisling Capital Management LP | 4,589,611 | $341.8M | 72.48% | −500,000−9.8% | Reduced |
Holders of 5% or more of BBIO
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of BridgeBio Pharma, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Janus Henderson Group PLC | 13G/A | 6.80%13.2M shares | +1.10 ppfrom 5.70% | Feb 17, 20262 filings | May 15, 2026 | SEC |
| Farallon Capital Management, L.L.C. | 13G/A | 5.50%10.7M shares | – | Aug 3, 20261 filing | Aug 3, 2026 | SEC |
| Farallon Capital Partners, L.P. | 13G | 5.20%10.2M shares | New | May 29, 20261 filing | May 29, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.10%9.89M shares | +0.14 ppfrom 4.96% | Oct 22, 20244 filings | Oct 27, 2026 | SEC |
| Viking Global Investors LPSuperinvestorViking Global Investors | 13D/A | 5.00%9.79M shares | −1.10 ppfrom 6.10% | Jul 20, 202312 filings | Jul 10, 2026 | SEC |
Politician trades
All politician trades in BBIO1 member of Congress reported 8 trades in BridgeBio Pharma, Inc. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Oct 12, 2026 |  Gilbert Ray Cisneros, Jr. House · CA | Sell (partial) | $1K-$15K |
| Jun 8, 2026 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| May 8, 2026 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Apr 7, 2026 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
| Apr 7, 2026 | Gilbert Ray Cisneros, Jr. House · CA | Buy | $1K-$15K |
House · CA · Oct 12, 2026
Sell (partial)$1K-$15K
House · CA · Jun 8, 2026
Buy$1K-$15K
House · CA · May 8, 2026
Buy$1K-$15K
House · CA · Apr 7, 2026
Buy$1K-$15K
House · CA · Apr 7, 2026
Buy$1K-$15K